Literature DB >> 9655704

Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood.

P G Gibson1, J W Wlodarczyk, M J Hensley, M Gleeson, R L Henry, A W Cripps, R L Clancy.   

Abstract

The role of airway inflammation in childhood asthma is not well defined, despite modern treatment approaches recommending potent anti-inflammatory therapy for an increasing number of children. In this study, induced sputum analysis was used to investigate the relationships among sputum inflammatory cells (eosinophils and mast cells), asthma symptoms, and airway hyperresponsiveness to hypertonic saline in a cohort of 170 children aged 8-14 years. Children who reported asthma symptoms in the past 2 wk had a 2. 25-fold (95% to CI, 1.20-4.24) increased odds of having significant sputum eosinophilia. Hyperresponsiveness to hypertonic saline was strongly associated with higher levels of sputum eosinophils ([OR] 4. 36, 1.70-11.20), sputum mast cells (OR 7.46, 2.48-22.75), and nasal eosinophils (OR 4.73, 1.89-11.86). Interestingly, boys were more likely than girls to have features of airway inflammation (sputum mast cells, OR 3.33, 1.15-9.65; nasal eosinophils, OR 3.25, 1.72-5. 97), which is consistent with the known increase in asthma prevalence in boys in this age group. Airway inflammation with eosinophils and mast cells is likely to be important in the pathogenesis of asthma in childhood. Induced sputum analysis can be used to evaluate this problem and has the potential to be a useful tool for monitoring therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9655704     DOI: 10.1164/ajrccm.158.1.9705031

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  52 in total

Review 1.  Association of sputum parameters with clinical and functional measurements in asthma.

Authors:  E Rosi; G Scano
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms.

Authors:  J D Leuppi; S H Downs; S R Downie; G B Marks; C M Salome
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 3.  The role of inflammation in childhood asthma.

Authors:  F Chedevergne; M Le Bourgeois; J de Blic; P Scheinmann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

4.  Relationship among pulmonary function, bronchial hyperresponsiveness, and atopy in children with clinically stable asthma.

Authors:  Eugene Yang; Woojung Kim; Byoung Chul Kwon; Sung Yeon Choi; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

5.  Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.

Authors:  N M Wilson; P Bridge; A Spanevello; M Silverman
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

6.  Innate immune activation in neutrophilic asthma and bronchiectasis.

Authors:  Jodie L Simpson; Terry V Grissell; Jeroen Douwes; Rodney J Scott; Michael J Boyle; Peter G Gibson
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

7.  Determination of Montelukast in Plasma Using β - Cyclodextrins Coated on CoFe2O4 Magnetic Nanoparticles in Luminol-H2O2 Chemiluminescence System Optimized by Doehlert Design.

Authors:  Abdolraouf Samadi-Maybodi; Alireza Bakhtiar; Mohammad Hossein Fatemi
Journal:  J Fluoresc       Date:  2016-03-15       Impact factor: 2.217

8.  Comparative clinical evaluation of ketotifen and montelukast sodium in asthmatic Iraqi patients.

Authors:  Fadyia Y Al-Hamdani
Journal:  Saudi Pharm J       Date:  2010-07-29       Impact factor: 4.330

Review 9.  Non-eosinophilic asthma: importance and possible mechanisms.

Authors:  J Douwes; P Gibson; J Pekkanen; N Pearce
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

10.  Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma.

Authors:  P G Gibson; J L Simpson; R Hankin; H Powell; R L Henry
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.